Sinopharm Group Co. Ltd (X2S) — Net Asset Quality Index
Sinopharm Group Co. Ltd (X2S) has a Net Asset Quality Index of 34.4% as of December 2025. This metric measures the proportion of total assets financed by shareholders' equity — total assets of €390.36 Billion minus total liabilities of €256.20 Billion yields net assets of €134.16 Billion. A higher index indicates a stronger, lower-leverage balance sheet. Read how much debt does Sinopharm Group Co. Ltd carry for a breakdown of total debt and financial obligations.
Quality Index
Net Assets
Total Assets
Total Liabilities
Sinopharm Group Co. Ltd Net Asset Quality Index Over Time (2013–2025)
This chart shows how Sinopharm Group Co. Ltd's Net Asset Quality Index has evolved across 13 annual periods from 2013 to 2025. As of December 2025, the index stands at 34.4%, representing net assets of €134.16 Billion against total assets of €390.36 Billion EUR. For live market cap and overall valuation, see market cap of Sinopharm Group Co. Ltd.
Annual Net Asset Quality Index for Sinopharm Group Co. Ltd (2013–2025)
The table below presents the year-by-year Net Asset Quality Index for Sinopharm Group Co. Ltd from 2013 to 2025, covering 13 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. Check Sinopharm Group Co. Ltd (X2S) strategic investment index to assess the company's strategic physical and investment asset allocation.
| Year | Quality Index | Net Assets (EUR) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 34.4% | €134.16 Billion | €390.36 Billion | €256.20 Billion | ▲ +2.1 pp |
| 2024 | 32.2% | €126.69 Billion | €392.83 Billion | €266.14 Billion | ▲ +0.9 pp |
| 2023 | 31.4% | €120.32 Billion | €383.39 Billion | €263.08 Billion | ▲ +1.2 pp |
| 2022 | 30.2% | €110.07 Billion | €364.78 Billion | €254.71 Billion | ▲ +0.5 pp |
| 2021 | 29.7% | €99.65 Billion | €335.41 Billion | €235.76 Billion | ▲ +0.8 pp |
| 2020 | 28.9% | €89.95 Billion | €311.24 Billion | €221.29 Billion | ▲ +0.4 pp |
| 2019 | 28.5% | €76.94 Billion | €269.89 Billion | €192.95 Billion | ▼ -0.5 pp |
| 2018 | 29.0% | €68.28 Billion | €235.77 Billion | €167.50 Billion | ▼ -1.3 pp |
| 2017 | 30.2% | €51.27 Billion | €169.54 Billion | €118.27 Billion | ▲ +2.0 pp |
| 2016 | 28.2% | €44.53 Billion | €157.71 Billion | €113.18 Billion | ▼ -1.1 pp |
| 2015 | 29.3% | €40.88 Billion | €139.43 Billion | €98.55 Billion | ▲ +1.1 pp |
| 2014 | 28.2% | €36.29 Billion | €128.66 Billion | €92.37 Billion | ▲ +1.1 pp |
| 2013 | 27.1% | €28.61 Billion | €105.45 Billion | €76.84 Billion | — |